ﬁt should be considered,
irrespective of the blood glucose level.
SGLT-2 inhibitors should not be started in drug naïve people with a
diabetes related foot ulcer or gangrene and temporary discontinuation should be considered in people already using these drugs, until
the affected foot is healed.

DISCLAIMER
The Society for Vascular Surgery (SVS) develops evidenced-based clinical practice guidelines as a resource
to assist members in the practice of vascular surgery.
The guideline recommendations